XML 13 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
Jun. 30, 2018
Dec. 31, 2017
Current Assets:    
Cash and cash equivalents $ 865,654 $ 2,636,956
Accounts receivable, net 1,840,145 1,535,513
Accounts receivable, from related party 2,817,990 1,725,450
Note receivable from financing transaction, current 500,000
Prepaid expenses and other current assets 484,753 436,410
Deferred cost, related party 1,796,036 1,109,671
Inventories, net 2,310,330 3,379,209
Advances on contracts 861,782 697,192
Total current assets 10,976,690 12,020,401
Furniture, fixtures & equipment, net 105,529 141,760
Patents, net 2,320,392 2,789,748
Note receivable from financing transaction, noncurrent 650,000
Other assets 26,878 26,878
Total assets 13,429,489 15,628,787
Current Liabilities:    
Accounts payable 1,365,491 853,859
Accounts payable, related party 1,352,802 1,109,442
Accrued expenses and other payables 1,937,571 2,287,908
Deferred profit, related party 636,126 751,500
Deferred revenue, related party 2,817,990 1,725,450
Total current liabilities 8,109,980 6,728,159
Deferred gain from financing transaction 1,400,000
Total liabilities 8,109,980 8,128,159
Commitments and Contingencies
Stockholders’ Equity    
Series A convertible preferred stock, par value $.001, authorized 5,000,000 shares, and 7,000 shares issued and outstanding as of June 30, 2018 and December 31, 2017 7 7
Common stock, par value $.001; authorized 50,000,000 shares; 33,660,970 shares issued, 1,912,503 shares to be issued and 33,627,637 shares outstanding as of June 30, 2018; 33,191,571 shares issued, 1,401,247 shares to be issued and 33,158,238 shares outstanding as of December 31, 2017; 35,571 34,593
Additional Paid in Capital 87,832,358 86,689,084
Accumulated deficit (81,784,998) (78,568,284)
Treasury stock, at cost, 33,333 shares (911,516) (911,516)
Total Milestone Scientific Inc. stockholders' equity 5,171,422 7,243,884
Noncontrolling interest 148,087 256,744
Total stockholders’ equity 5,319,509 7,500,628
Total liabilities and stockholders’ equity $ 13,429,489 $ 15,628,787